These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15003084)

  • 41. Risperidone-induced anxiety might also develop 'awakening' phenomenon.
    Hori M; Shiraishi H
    Psychiatry Clin Neurosci; 1999 Dec; 53(6):682. PubMed ID: 10687752
    [No Abstract]   [Full Text] [Related]  

  • 42. [Neuroleptic malignant syndrome in users of risperidone].
    Bonte-Mineur F; Geerlings CJ; Rietveld AP
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):158-9; author reply 159. PubMed ID: 15693595
    [No Abstract]   [Full Text] [Related]  

  • 43. Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study.
    Friedel RO; Jackson WT; Huston CS; May RS; Kirby NL; Stoves A
    J Clin Psychopharmacol; 2008 Jun; 28(3):345-7. PubMed ID: 18480695
    [No Abstract]   [Full Text] [Related]  

  • 44. Risperidone and tardive dyskinesia in organic psychosis.
    Fischer P; Tauscher J; Küfferle B
    Pharmacopsychiatry; 1998 Mar; 31(2):70-1. PubMed ID: 9562212
    [No Abstract]   [Full Text] [Related]  

  • 45. Olanzapine-induced somnambulism.
    Kolivakis TT; Margolese HC; Beauclair L; Chouinard G
    Am J Psychiatry; 2001 Jul; 158(7):1158. PubMed ID: 11431244
    [No Abstract]   [Full Text] [Related]  

  • 46. Risperidone and withdrawal dyskinesia.
    Lore C
    J Am Acad Child Adolesc Psychiatry; 2000 Aug; 39(8):941. PubMed ID: 10939219
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric outpatients].
    Kurz A; Delius-Stute H; Rettig K; Schwalen S
    MMW Fortschr Med; 2003 Oct; 145(42):55. PubMed ID: 14655446
    [No Abstract]   [Full Text] [Related]  

  • 48. Risperidone-Induced Acute Respiratory Distress in an Adolescent with Autism.
    Chen F
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):851-852. PubMed ID: 27220113
    [No Abstract]   [Full Text] [Related]  

  • 49. Risperidone treatment of bipolar disorder.
    McIntyre R; Young LT; Hasey G; Patelis-Siotis I; Jones BD
    Can J Psychiatry; 1997 Feb; 42(1):88-90. PubMed ID: 9040930
    [No Abstract]   [Full Text] [Related]  

  • 50. Comment on "dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia".
    Ishitobi M; Kosaka H; Shukunami K; Murata T; Wada Y
    J Clin Psychopharmacol; 2011 Jun; 31(3):400-1; author reply 401. PubMed ID: 21532377
    [No Abstract]   [Full Text] [Related]  

  • 51. Risperidone-induced mania.
    Zolezzi M; Badr MG
    Ann Pharmacother; 1999 Mar; 33(3):380-1. PubMed ID: 10200867
    [No Abstract]   [Full Text] [Related]  

  • 52. Evaluation of risperidone in the treatment of behavioral and psychological symptoms and sleep disturbances associated with dementia.
    Durán JC; Greenspan A; Diago JI; Gallego R; Martinez G
    Int Psychogeriatr; 2005 Dec; 17(4):591-604. PubMed ID: 16202185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risperidone and dementia-related aggression: new indication. A last resort, no better than haloperidol.
    Prescrire Int; 2009 Dec; 18(104):248. PubMed ID: 20025088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risperidone-induced paroxysmal perceptual alteration in a child with autism.
    Bozkurt H; Ayaydın H; Adak İ; Zoroğlu SS
    J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):470-1. PubMed ID: 23234592
    [No Abstract]   [Full Text] [Related]  

  • 55. Risperidone and cognitive functioning in elderly schizophrenic patients.
    Reznik I; Paleacu D
    Am J Geriatr Psychiatry; 2000; 8(2):177. PubMed ID: 10804081
    [No Abstract]   [Full Text] [Related]  

  • 56. Risperidone-induced tardive dyskinesia.
    Silberbauer C
    Pharmacopsychiatry; 1998 Mar; 31(2):68-9. PubMed ID: 9562211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Probable induction of mania by risperidone.
    Koek RJ; Kessler CC
    J Clin Psychiatry; 1996 Apr; 57(4):174-5. PubMed ID: 8601554
    [No Abstract]   [Full Text] [Related]  

  • 59. Prolactogenic effects of risperidone in male patients--a preliminary study.
    Shiwach RS; Carmody TJ
    Acta Psychiatr Scand; 1998 Jul; 98(1):81-3. PubMed ID: 9696519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
    Freund-Levi Y; Bloniecki V; Auestad B; Tysen Bäckström AC; Lärksäter M; Aarsland D
    Dement Geriatr Cogn Disord; 2014; 38(3-4):234-44. PubMed ID: 24969380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.